Table 1. Characteristics of control and POAG groups.
| Parameter |
Control | POAG stage |
||||||
|---|---|---|---|---|---|---|---|---|
| IIA | IIB | IIIB | IIIC | IVC | Total | |||
| Number of participants |
9 |
12 |
11 |
21 |
19 |
4 |
67 |
|
| Mean age ± SD, years* |
46.55±10.21 |
66.17±8.11 |
66.27±8.22 |
70.00±7.76 |
64.05±9.81 |
72.50±10.34 |
67.16±8.83 |
|
| Gender, %** |
Male |
55.6 |
76.7 |
45.5 |
38.1 |
47.4 |
50 |
47.8 |
| Female |
44.4 |
33.3 |
54.5 |
61.9 |
52.6 |
50 |
52.2 |
|
| IOP ± SD, mmHg |
- |
20.0±0.95 |
24.8±2.8 |
25.2±3.1 |
32.1±1.9 |
35.3±3.9 |
- |
|
| Refraction
abnormalities, % |
Myopia*** |
- |
8.3 |
18.2 |
9.5 |
21.05 |
- |
13.4 |
| Hyperopia |
- |
- |
- |
- |
10.5 |
- |
3.0 |
|
| Comorbidities, % | Arterial hypertension |
55.55 |
75.0 |
54.5 |
85.7 |
57.9 |
75.0 |
70.1 |
| Coronary heart disease |
55.55 |
41.7 |
36.4 |
76.2 |
26.3 |
25.0 |
46.3 |
|
| Diabetes mellitus | - | - | 18.2 | 14.3 | 10.5 | - | 10.4 | |
* No significant age differences between glaucoma groups (p=0.119); ** No significant gender differences between all groups (p=0.605); *** No significant correlation with POAG stage (R=0.21; p=0.320).